Compounds > pyrazinoic acid

pyrazinoic acid and rifampin

pyrazinoic acid has been researched along with rifampin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acocella, G; Carlone, NA; Cuffini, AM; Forno-Pizzoglio, M1
Acocella, G; Conti, R; Grassi, C; Luisetti, M; Pozzi, E1
Acocella, G; Carlone, NA; Cavallo, G; Cuffini, AM1
Acharyulu, GS; Gurumurthy, P; Kannapiran, M; Murthy, PV; Sarma, GR; Tripathy, SP1
Wade, MM; Zhang, Y1
Braunstein, M; Durham, PG; Hayden, JD; Hickey, AJ; Lin, FC; Miller, BK; Montgomery, SA; Rank, L; Welch, JT; Young, EF; Zulauf, KE1

Other Studies

6 other study(ies) available for pyrazinoic acid and rifampin

ArticleYear
Killing of macrophage-ingested mycobacteria by rifampicin, pyrazinamide, and pyrazinoic acid alone and in combination.
    The American review of respiratory disease, 1985, Volume: 132, Issue:6

    Topics: Animals; Antitubercular Agents; Drug Combinations; Macrophages; Male; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phagocytosis; Pyrazinamide; Rifampin

1985
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study.
    The American review of respiratory disease, 1985, Volume: 132, Issue:3

    Topics: Absorption; Antitubercular Agents; Humans; Isoniazid; Kinetics; Male; Pyrazinamide; Rifampin; Streptomycin

1985
The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophages.
    The American review of respiratory disease, 1985, Volume: 132, Issue:6

    Topics: Animals; Binding Sites; Biological Transport; Cells, Cultured; Dose-Response Relationship, Drug; Macrophages; Male; Mice; Mice, Inbred BALB C; Pyrazinamide; Rifampin

1985
Role of rifampicin in arthralgia induced by pyrazinamide.
    Tubercle, 1983, Volume: 64, Issue:2

    Topics: Drug Therapy, Combination; Humans; Joint Diseases; Pain; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Uric Acid

1983
Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.
    Journal of medical microbiology, 2004, Volume: 53, Issue:Pt 8

    Topics: Adenosine Triphosphatases; Anaerobiosis; Antitubercular Agents; Colony Count, Microbial; Electron Transport; Energy Metabolism; Enzyme Inhibitors; Isoniazid; Mycobacterium tuberculosis; Nitrates; Oxygen; Pyrazinamide; Rifampin

2004
Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.
    PloS one, 2018, Volume: 13, Issue:9

    Topics: Aerosols; Animals; Antitubercular Agents; Bacterial Load; Disease Models, Animal; Drug Therapy, Combination; Dry Powder Inhalers; Granuloma, Respiratory Tract; Guinea Pigs; Male; Mycobacterium tuberculosis; Necrosis; Pyrazinamide; Respiratory Tract Absorption; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2018